Zusammenfassung: | |
Functional vascularization is a prerequisite for cardiac tissue engineering of constructs with physiological thicknesses. We previously reported the successful preservation of main vascular conduits in isolated thick acellular porcine cardiac ventricular ECM (pcECM). We now unveil this scaffold's potential in supporting human cardiomyocytes and promoting new blood vessel development ex vivo, providing long-term cell support in the construct bulk. A custom-designed perfusion bioreactor was developed to remodel such vascularization ex vivo, demonstrating, for the first time, functional angiogenesis in vitro with various stages of vessel maturation supporting up to 1.7 mm thick constructs. A robust methodology was developed to assess the pcECM maximal cell capacity, which resembled the human heart cell density. Taken together these results demonstrate feasibility of producing physiological-like constructs such as the thick pcECM suggested here as a prospective treatment for end-stage heart failure. Methodologies reported herein may also benefit other tissues, offering a valuable in vitro setting for "thick-tissue" engineering strategies toward large animal in vivo studies.
|
|
Lizenzbestimmungen: | CC BY-NC 4.0 Unported - https://creativecommons.org/licenses/by-nc/4.0/ |
Publikationstyp: | Article |
Publikationsstatus: | publishedVersion |
Erstveröffentlichung: | 2015 |
Schlagwörter (englisch): | Blood vessels, Heart, Physiology, Scaffolds (biology), Tissue, Cardiac tissue engineering, Cardiomyocytes, Cell capacity, Extracellular matrices, Heart failure, Perfusion bioreactor, Vascularization, Vessel development, Tissue engineering, angiogenesis, animal tissue, cardiac ventricular extracellular matrix, cell density, controlled study, ex vivo study, extracellular matrix, heart muscle cell, human, human cell, in vitro study, nonhuman, priority journal, Animalia, Sus |
Fachliche Zuordnung (DDC): | 610 | Medizin, Gesundheit |
Anzeige der Dokumente mit ähnlichem Titel, Autor, Urheber und Thema.